מדינה: הממלכה המאוחדת
שפה: אנגלית
מקור: VMD (Veterinary Medicines Directorate)
Ampicillin
Cross Vetpharm Group Ltd
QJ01CA01
Ampicillin
Expired
Revised: December 2010 AN: 01369/2010 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ampicillinvet 250mg Hard Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains: Active Ingredient mg per capsule Ampicillin 250 _ _ (as ampicillin trihydrate) Capsule Body Erythrosine (E127) 0.952 Quinoline yellow (E104) 0.004 Patent blue V (E131) 0.002 Titanium dioxide (E171) 0.368 Capsule cap Ferric oxide black (E172) 0.146 Titanium dioxide (E171) 0.488 Ink: Black iron oxide (E172) For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Capsules, hard Red and grey hard capsules with the logo ‘AMP/250’ in black ink 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs Page 1 of 6 Revised: December 2010 AN: 01369/2010 4.2 INDICATIONS FOR USE Ampicillinvet is indicated in the treatment and control of diseases caused by or associated with bacterial pathogens sensitive to ampicillin. These include the following groups of pathogens: Streptococcus spp, Pasturella haemolytica, P. multocida, Staphylococcus aureus and other pathogenic staphylococci When susceptible organisms are present, treatment with Ampicillinvet may be effective in the following indications: Alimentary tract infections Respiratory infections Urinary tract infections 4.3 CONTRAINDICATIONS Not to be administered to animals known to be sensitive to penicillin. Not to be administered to small herbivores. Do not treat dogs of less than 10kg bodyweight. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE, INCLUDING SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO THE ANIMALS i. Specials precautions for use in animals Whenever possible, the Ampicillinvet Capsules s קרא את המסמך השלם